The antitumoral effectiveness of high-level anti-huHER2 antibodies elicited by HuRT-DNA vaccine in tolerant hosts was therefore tested according to their ability to hamper the growth of human HER2-positive cancer cells in immunodeficient mice. The gene discussed is ERBB2; the disease is cancer.